WallStSmart
APLM

Apollomics Inc. Class A Ordinary Shares

NASDAQ: APLM · HEALTHCARE · BIOTECHNOLOGY

$13.08
+1.75% today

Updated 2026-04-29

Market cap
$28.71M
P/E ratio
P/S ratio
3.19x
EPS (TTM)
$-7.57
Dividend yield
52W range
$4 – $40
Volume
0.0M

WallStSmart proprietary scores

36
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A
5.3
Quality
C+
4.0
Profitability
C
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$2.00
-84.70%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 380.80% QoQ
+ Debt/equity -0.17x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at -121.60%
- Negative free cash flow $-10.37M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$323000.00$821000.00$198000.00$8.50M$8.99M
Net income$-240.81M$-172.60M$-53.86M$-10.94M$-10.94M
EPS$-7.57
Free cash flow$-43.19M$-43.22M$-28.77M$-10.37M$-10.37M
Profit margin-74,554.49%-21,023.26%-27,201.01%-128.69%-121.60%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
APLM$28.71M368.04.05.05.3Hold
LLY$789.69B7810.010.05.06.5Strong Buy
JNJ$547.64B594.79.03.36.0-41.97%Buy
ABBV$351.47B634.08.04.75.0-24.92%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Apollomics Inc. Class A Ordinary Shares trades at $13.08. Our Smart Value Score of 36/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $8.99M. with profit margins at -121.60%.

Frequently asked questions

What is Apollomics Inc. Class A Ordinary Shares's stock price?
Apollomics Inc. Class A Ordinary Shares (APLM) trades at $13.08.
Is Apollomics Inc. Class A Ordinary Shares overvalued?
Smart Value Score 36/100 (Grade D, Sell).
What is the price target of Apollomics Inc. Class A Ordinary Shares (APLM)?
The analyst target price is $2.00, representing -84.7% downside from the current price of $13.08.
What is Apollomics Inc. Class A Ordinary Shares's revenue?
TTM revenue is $8.99M.
Piotroski F-Score?
3/9 — weak financial health.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio3.19x
ROE-1,305.00%
Beta1.83
50D MA$17.22
200D MA$15.51
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years